Analytical Data
-
Gene name
LRP5L
- Application
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
A4QPB2
-
Expression Region
Trp7~Pro238
-
Molecular Weight
32kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LRP5L (Low-Density Lipoprotein Receptor-related Protein 5 Like) is a member of the LRP family, which plays a vital role in various biological processes, including lipid metabolism, cell signaling, and the regulation of developmental pathways. Research on LRP5L has gained significant attention due to its potential involvement in critical cellular functions and its implications in various diseases. The protein's structure, similar to other LRP family members, suggests that it may interact with multiple ligands and signaling molecules, impacting processes such as bone formation and neuronal function. Additionally, aberrations in LRP5L expression and function have been linked to conditions like osteoporosis, obesity, and neurodegenerative diseases. Given the growing interest in LRP5L as a therapeutic target, studies are increasingly focused on characterizing the recombinant forms of this protein to elucidate its biological role and mechanism of action. By understanding LRP5L's interactions and pathways, researchers hope to develop novel strategies for treatment and prevention of related diseases, contributing to the broader field of molecular biology and therapeutic development.
